Lippo Limited Logo

Lippo Limited

0226.HK

(1.8)
Stock Price

0,72 HKD

0.15% ROA

0.37% ROE

21.45x PER

Market Cap.

519.765.722,00 HKD

21.66% DER

0% Yield

3.01% NPM

Lippo Limited Stock Analysis

Lippo Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Lippo Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.05x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a low debt to equity ratio (21%), which means it has a small amount of debt compared to the ownership it holds

3 ROE

The stock's ROE falls within an average range (1.3%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (0.8%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-34) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Lippo Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Lippo Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Sell
4 Stoch RSI Buy

Lippo Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Lippo Limited Revenue
Year Revenue Growth
2002 1.116.370.000
2003 1.811.747.000 38.38%
2004 2.827.300.000 35.92%
2005 2.485.931.000 -13.73%
2006 1.549.663.000 -60.42%
2007 1.257.066.000 -23.28%
2008 579.322.000 -116.99%
2009 1.454.969.000 60.18%
2010 397.530.000 -266%
2011 338.162.000 -17.56%
2012 2.828.685.600 88.05%
2013 6.732.004.000 57.98%
2014 2.974.195.000 -126.35%
2015 3.856.686.000 22.88%
2016 2.670.386.000 -44.42%
2017 2.514.404.000 -6.2%
2018 2.554.210.000 1.56%
2019 925.155.000 -176.08%
2020 925.155.000 0%
2020 764.807.421 -20.97%
2021 728.174.000 -5.03%
2022 677.773.000 -7.44%
2023 773.804.000 12.41%
2023 813.522.000 4.88%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Lippo Limited Research and Development Expenses
Year Research and Development Expenses Growth
2002 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 -1 0%
2023 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Lippo Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 221.372.000
2003 205.380.000 -7.79%
2004 235.627.000 12.84%
2005 238.811.000 1.33%
2006 196.960.000 -21.25%
2007 246.096.000 19.97%
2008 251.530.000 2.16%
2009 272.087.000 7.56%
2010 247.632.000 -9.88%
2011 206.030.000 -20.19%
2012 924.170.400 77.71%
2013 983.119.000 6%
2014 1.042.409.000 5.69%
2015 901.346.000 -15.65%
2016 813.916.000 -10.74%
2017 748.611.000 -8.72%
2018 798.602.000 6.26%
2019 632.011.000 -26.36%
2020 632.011.000 0%
2020 402.329.233 -57.09%
2021 438.823.000 8.32%
2022 420.678.000 -4.31%
2023 415.596.000 -1.22%
2023 442.360.000 6.05%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Lippo Limited EBITDA
Year EBITDA Growth
2002 2.819.000
2003 270.748.000 98.96%
2004 79.007.000 -242.69%
2005 179.279.000 55.93%
2006 632.237.000 71.64%
2007 8.318.000 -7500.83%
2008 -515.032.000 101.62%
2009 218.298.000 335.93%
2010 2.251.071.000 90.3%
2011 860.497.000 -161.6%
2012 36.988.800 -2226.37%
2013 1.377.334.000 97.31%
2014 428.321.000 -221.57%
2015 18.475.000 -2218.38%
2016 156.000.000 88.16%
2017 308.047.000 49.36%
2018 -166.708.000 284.78%
2019 334.895.000 149.78%
2020 288.731.000 -15.99%
2020 979.168.218 70.51%
2021 607.400.000 -61.21%
2022 454.803.000 -33.55%
2023 -45.544.000 1098.6%
2023 26.622.000 271.08%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Lippo Limited Gross Profit
Year Gross Profit Growth
2002 356.095.000
2003 615.836.000 42.18%
2004 492.345.000 -25.08%
2005 627.760.000 21.57%
2006 377.613.000 -66.24%
2007 387.038.000 2.44%
2008 298.095.000 -29.84%
2009 511.840.000 41.76%
2010 337.457.000 -51.68%
2011 299.943.000 -12.51%
2012 1.352.008.800 77.82%
2013 3.174.700.000 57.41%
2014 1.377.421.000 -130.48%
2015 1.652.624.000 16.65%
2016 1.291.007.000 -28.01%
2017 1.134.050.000 -13.84%
2018 1.147.867.000 1.2%
2019 640.203.000 -79.3%
2020 640.203.000 0%
2020 440.102.900 -45.47%
2021 407.272.000 -8.06%
2022 385.093.000 -5.76%
2023 455.630.000 15.48%
2023 502.214.000 9.28%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Lippo Limited Net Profit
Year Net Profit Growth
2002 -101.676.000
2003 167.488.000 160.71%
2004 178.438.000 6.14%
2005 277.599.000 35.72%
2006 261.414.000 -6.19%
2007 1.463.630.000 82.14%
2008 -336.744.000 534.64%
2009 1.254.000 26953.59%
2010 1.684.537.000 99.93%
2011 594.533.000 -183.34%
2012 -8.001.600 7530.18%
2013 112.173.000 107.13%
2014 552.223.000 79.69%
2015 -186.565.000 395.99%
2016 431.025.000 143.28%
2017 245.253.000 -75.75%
2018 -112.191.000 318.6%
2019 -10.315.000 -987.65%
2020 183.700.000 105.62%
2020 -214.360.800 185.7%
2021 675.872.000 131.72%
2022 125.281.000 -439.48%
2023 5.422.000 -2210.6%
2023 -35.381.000 115.32%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Lippo Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 1 0%
2007 2 100%
2008 -1 0%
2009 0 0%
2010 3 100%
2011 1 -200%
2012 0 0%
2013 0 0%
2014 2 100%
2015 0 0%
2016 1 0%
2017 1 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 1 100%
2022 0 0%
2023 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Lippo Limited Free Cashflow
Year Free Cashflow Growth
2002 -176.472.000
2003 971.844.000 118.16%
2004 -9.147.000 10724.73%
2005 131.859.000 106.94%
2006 459.077.000 71.28%
2007 337.419.000 -36.06%
2008 -61.998.000 644.24%
2009 214.518.000 128.9%
2010 -84.167.000 354.87%
2011 -219.213.000 61.6%
2012 174.886.400 225.35%
2013 1.430.734.000 87.78%
2014 -999.518.000 243.14%
2015 -5.093.000 -19525.33%
2016 189.519.000 102.69%
2017 -506.360.000 137.43%
2018 218.636.000 331.6%
2019 -351.335.000 162.23%
2020 -156.829.295 -124.02%
2021 56.393.000 378.1%
2022 -77.760.000 172.52%
2023 -10.100.000 -669.9%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Lippo Limited Operating Cashflow
Year Operating Cashflow Growth
2002 -162.347.000
2003 981.946.000 116.53%
2004 79.943.000 -1128.31%
2005 464.922.000 82.81%
2006 581.312.000 20.02%
2007 543.444.000 -6.97%
2008 337.757.000 -60.9%
2009 457.882.000 26.23%
2010 250.475.000 -82.81%
2011 237.607.000 -5.42%
2012 306.912.800 22.58%
2013 1.527.001.000 79.9%
2014 -845.233.000 280.66%
2015 44.452.000 2001.45%
2016 214.945.000 79.32%
2017 -364.916.000 158.9%
2018 379.567.000 196.14%
2019 -196.478.000 293.19%
2020 -88.590.645 -121.78%
2021 96.666.000 191.65%
2022 -39.568.000 344.3%
2023 174.000 22840.23%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Lippo Limited Capital Expenditure
Year Capital Expenditure Growth
2002 14.125.000
2003 10.102.000 -39.82%
2004 89.090.000 88.66%
2005 333.063.000 73.25%
2006 122.235.000 -172.48%
2007 206.025.000 40.67%
2008 399.755.000 48.46%
2009 243.364.000 -64.26%
2010 334.642.000 27.28%
2011 456.820.000 26.75%
2012 132.026.400 -246.01%
2013 96.267.000 -37.15%
2014 154.285.000 37.6%
2015 49.545.000 -211.4%
2016 25.426.000 -94.86%
2017 141.444.000 82.02%
2018 160.931.000 12.11%
2019 154.857.000 -3.92%
2020 68.238.650 -126.93%
2021 40.273.000 -69.44%
2022 38.192.000 -5.45%
2023 10.274.000 -271.73%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Lippo Limited Equity
Year Equity Growth
2002 2.640.038.000
2003 2.800.472.000 5.73%
2004 3.061.206.000 8.52%
2005 3.369.542.000 9.15%
2006 3.740.431.000 9.92%
2007 4.790.057.000 21.91%
2008 4.690.236.000 -2.13%
2009 4.701.052.000 0.23%
2010 7.264.078.000 35.28%
2011 7.890.504.000 7.94%
2012 8.848.562.000 10.83%
2013 8.631.161.000 -2.52%
2014 9.297.824.000 7.17%
2015 9.143.044.000 -1.69%
2016 14.214.737.000 35.68%
2017 15.187.808.000 6.41%
2018 15.211.458.000 0.16%
2019 13.528.519.000 -12.44%
2020 7.608.588.000 -77.81%
2021 14.137.437.000 46.18%
2022 13.216.979.000 -6.96%
2023 12.930.139.000 -2.22%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Lippo Limited Assets
Year Assets Growth
2002 8.134.821.000
2003 8.229.909.000 1.16%
2004 8.612.168.000 4.44%
2005 9.449.698.000 8.86%
2006 11.242.200.000 15.94%
2007 13.003.482.000 13.54%
2008 12.546.472.000 -3.64%
2009 12.037.586.000 -4.23%
2010 16.420.080.000 26.69%
2011 18.503.171.000 11.26%
2012 22.767.561.000 18.73%
2013 19.939.519.000 -14.18%
2014 19.271.322.000 -3.47%
2015 17.456.646.000 -10.4%
2016 18.484.016.000 5.56%
2017 19.571.337.000 5.56%
2018 18.697.628.000 -4.67%
2019 16.157.585.000 -15.72%
2020 16.323.635.000 1.02%
2021 16.596.608.000 1.64%
2022 15.591.777.000 -6.44%
2023 15.271.196.000 -2.1%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Lippo Limited Liabilities
Year Liabilities Growth
2002 2.322.080.000
2003 2.410.431.000 3.67%
2004 2.379.333.000 -1.31%
2005 2.693.386.000 11.66%
2006 4.376.793.000 38.46%
2007 4.624.716.000 5.36%
2008 4.454.395.000 -3.82%
2009 3.993.566.000 -11.54%
2010 4.018.589.000 0.62%
2011 5.097.934.000 21.17%
2012 7.815.029.000 34.77%
2013 4.457.266.000 -75.33%
2014 4.462.417.000 0.12%
2015 2.982.442.000 -49.62%
2016 4.269.279.000 30.14%
2017 4.383.529.000 2.61%
2018 3.486.170.000 -25.74%
2019 2.629.066.000 -32.6%
2020 2.683.918.000 2.04%
2021 2.459.171.000 -9.14%
2022 2.374.798.000 -3.55%
2023 2.341.057.000 -1.44%

Lippo Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.52
Net Income per Share
0.05
Price to Earning Ratio
21.45x
Price To Sales Ratio
0.69x
POCF Ratio
5.23
PFCF Ratio
10.03
Price to Book Ratio
0.05
EV to Sales
2.22
EV Over EBITDA
-23.41
EV to Operating CashFlow
18.02
EV to FreeCashFlow
32.12
Earnings Yield
0.05
FreeCashFlow Yield
0.1
Market Cap
0,52 Bil.
Enterprise Value
1,67 Bil.
Graham Number
4.35
Graham NetNet
-2.56

Income Statement Metrics

Net Income per Share
0.05
Income Quality
4.1
ROE
0
Return On Assets
0
Return On Capital Employed
-0.02
Net Income per EBT
-0.11
EBT Per Ebit
1.43
Ebit per Revenue
-0.2
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
0.55
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.58
Operating Profit Margin
-0.2
Pretax Profit Margin
-0.28
Net Profit Margin
0.03

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.19
Free CashFlow per Share
0.11
Capex to Operating CashFlow
-0.44
Capex to Revenue
-0.05
Capex to Depreciation
-0.3
Return on Invested Capital
-0.02
Return on Tangible Assets
0
Days Sales Outstanding
0
Days Payables Outstanding
209.83
Days of Inventory on Hand
127.93
Receivables Turnover
0
Payables Turnover
1.74
Inventory Turnover
2.85
Capex per Share
-0.08

Balance Sheet

Cash per Share
2,07
Book Value per Share
18,43
Tangible Book Value per Share
26.21
Shareholders Equity per Share
18.43
Interest Debt per Share
4.18
Debt to Equity
0.22
Debt to Assets
0.13
Net Debt to EBITDA
-16.1
Current Ratio
1.14
Tangible Asset Value
12,91 Bil.
Net Current Asset Value
-1,03 Bil.
Invested Capital
0.22
Working Capital
0,16 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,11 Bil.
Average Inventory
111362000
Debt to Market Cap
3.79

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Lippo Limited Dividends
Year Dividends Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Lippo Limited Profile

About Lippo Limited

Lippo Limited, an investment holding company, engages in the food, property investment and development, treasury investment, securities investment, healthcare services, mineral exploration and extraction, and other businesses. It manufactures, wholesales, and retails food products and beverages, as well as bakery and pastry products; and operates and manages restaurants, hotels, cafés, kiosks, bistros, and bakery corners. The company is also involved in the development, letting, sale, and resale of real estate properties; money market and securities investment activities; provision of healthcare management services; and exploration and extraction of minerals. In addition, it owns a motor yacht; invests in closed-end funds; and develops software products. Further, the company provides property, project, fund, and investment management services; money lending, management, commercial consulting, financing, and catering services, as well as real estate agency and consultancy services. It operates in Hong Kong, Mainland China, Republic of Singapore, Indonesia, Malaysia, and internationally. The company is headquartered in Central, Hong Kong. Lippo Limited is a subsidiary of Lippo Capital Limited.

CEO
Mr. Luen Wai Lee BBS, CPA, J.
Employee
786
Address
Tower Two
Central,

Lippo Limited Executives & BODs

Lippo Limited Executives & BODs
# Name Age
1 Dr. Stephen Riady
Chairman & Executive President
70
2 Mr. Kwok Fai Lee
Company Secretary
70
3 Mr. Luen Wai Lee BBS, CPA, J.P.
MD, Chief Executive Officer & Executive Director
70
4 Mr. Shiu Leung Au
Chief Financial Officer
70
5 Mr. Brian Riady
Executive Director
70

Lippo Limited Competitors